Concepedia

Chenling Meng

CM

Statistics

Publications

13

Citations

534

H-Index

11

Active since

2015

Affiliations

Chinese University of Hong Kong(Current)

Nanjing University

Model Animal Research Center

The University of Texas MD Anderson Cancer Center

The Seventh Affiliated Hospital of Sun Yat-sen University

Chenling Meng is an author at Chinese University of Hong Kong specializing in life sciences, signal transduction, and molecular biology.

Publications per year

2015–2025

13

Publications

13

Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate Cancer

Di Zhao, Li Cai, Xin Lü et al. · Cancer Discovery · 2020 · 110 citations · Full text

Medicine, Genetics, Oncology +17

RGMb protects against acute kidney injury by inhibiting tubular cell necroptosis via an MLKL-dependent mechanism

Wenjing Liu, Binbin Chen, Yang Wang et al. · Proceedings of the National Academy of Sciences · 2018 · 98 citations · Full text

Medicine, Cell Biology, Nephrology +17

Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies

Wei Shi, Yin Wang, Yuehui Zhao et al. · Science Translational Medicine · 2023 · 67 citations · Full text

Medicine, Immunology, Oncology +17

Tubule-Specific Mst1/2 Deficiency Induces CKD via YAP and Non-YAP Mechanisms

Chunhua Xu, Li Wang, Wenling Li et al. · Journal of the American Society of Nephrology · 2020 · 53 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

IL-1β inhibits β-Klotho expression and FGF19 signaling in hepatocytes

Yueshui Zhao, Chenling Meng, Yang Wang et al. · American Journal of Physiology-Endocrinology and Metabolism · 2015 · 42 citations · Full text

Life Sciences, Biochemistry, Cell Biology +13

1–5 of 13